Generation of fusion protein EGFRvIII-HBcAg and its anti-tumor effect in vivo

The epidermal growth factor receptor variant III (EGFRvIII) is the most common variation of EGFR. Because it shows a high frequency in several different types of tumor and has not been detected in normal tissues, it is an ideal target for tumor specific therapy. In this study, we prepared EGFRvIII-H...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Xiao-yi, Han, Dong-gang, Zhang, Ming-xin, Wang, Jian-sheng
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764640/
https://www.ncbi.nlm.nih.gov/pubmed/19788747
http://dx.doi.org/10.1186/1756-9966-28-133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764640/
https://www.ncbi.nlm.nih.gov/pubmed/19788747
http://dx.doi.org/10.1186/1756-9966-28-133

Ejemplares similares